RAHWAY, N.J.–()–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that Surendralal L. 鈥淟al鈥� Karsanbhai, president and chief executive officer, Emerson Electric Co. (NYSE: EMR), will join Merck鈥檚 board of directors effective January 1, 2025. He will stand for election by the company鈥檚 shareholders in May 2025. With the addition of Mr. Karsanbhai, the Merck board will consist of 13 members.
鈥淲e are pleased to welcome Lal Karsanbhai to the Merck board. Lal brings extensive business and operational expertise with a strong global perspective, and we look forward to his contributions and insights,鈥� said Robert M. Davis, chairman and chief executive officer, Merck.
Mr. Karsanbhai joined Emerson in 1995 and held various roles increasing in scope and responsibility before becoming Emerson鈥檚 president and chief executive officer and an executive director on its board in 2021. Mr. Karsanbhai also serves as deputy chair of the Federal Reserve Bank of St. Louis and on the board of the US-China Business Council. He holds a bachelor鈥檚 degree in economics from the University of Michigan and a master鈥檚 degree in business administration from Washington University in St. Louis.
About Merck
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world 鈥� and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit聽聽and connect with us on聽,听,听,听听补苍诲听.
